You may have seen on the news that GlaxoSmithKline (GSK) a huge drug company has 'challenged' the drug industry to make loads of drugs available more cheaply in poorer countries, invest a big slice of its profits into projects in the least developed countries and importantly, will release patents and IP relevant to research into 'neglected diseases'.
The cynics will note that 'neglected diseases' could also be termed 'not profitable diseases' but the release of information will still be useful nonetheless.
All good news, and hopefully will be followed by other drug companies, helping them to shed their terrible reputations for profiteering.
However, MSF and other respected NGOs are not happy that this new deal doesn't include HIV / AIDs drugs.
Without including these, GSK is getting a lot of good PR and spinning some nice publicity wins, but really, including HIV will save more lives.
Click here to read more from MSF on the GSK statement.
Sean
No comments:
Post a Comment